Study to Assess Epidural Resiniferatoxin for the Treatment of Intractable Pain Associated With Advanced Cancer

Clinical trial NCT05067257 · SUSPENDED

Trial details

NCT number: NCT05067257
Sponsor: Sorrento Therapeutics, Inc.
Status: SUSPENDED
Phase: Phase 2
Study type: INTERVENTIONAL

Pain, Intractable Pain Cancer Pain

Start date: 2025-09-01
Primary completion: 2027-06-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.